Predatory bacteria as living antibiotics - where are we now?

Animals Anti-Bacterial Agents / pharmacology Antibiosis Bdellovibrio bacteriovorus / genetics Drug Resistance, Bacterial Gram-Positive Bacteria / drug effects Gram-Positive Bacterial Infections / microbiology Humans
AMR Alternatives to antibiotics Antimicrobial resistance Bacteriophage Living antibiotics Predatory bacteria

Journal

Microbiology (Reading, England)
ISSN: 1465-2080
Titre abrégé: Microbiology (Reading)
Pays: England
ID NLM: 9430468

Informations de publication

Date de publication:
01 2021
Historique:
pubmed: 20 1 2021
medline: 25 8 2021
entrez: 19 1 2021
Statut: ppublish

Résumé

Antimicrobial resistance (AMR) is a global health and economic crisis. With too few antibiotics in development to meet current and anticipated needs, there is a critical need for new therapies to treat Gram-negative infections. One potential approach is the use of living predatory bacteria, such as

Identifiants

DOI: 10.1099/mic.0.001025 PMID: 33465024
pubmed: 33465024
doi: 10.1099/mic.0.001025
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Wellcome Trust
ID : 209437/Z/17/Z
Pays : United Kingdom

Auteurs

Robert J Atterbury (RJ)

School of Veterinary Medicine and Science, University of Nottingham, Sutton Bonington Campus, Leicestershire, LE12 5RD, UK.

Jess Tyson (J)

School of Life Sciences, University of Nottingham, Medical School, Queen's Medical Centre, Nottingham, NG7 2UH, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Predatory bacteria as living antibiotics -...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Anti-infectieux › Antibactériens › Predatory bacteria as living antibiotics -...
questionsmedicales.fr › Phénomènes biologiques › Antibiose › Predatory bacteria as living antibiotics -...
questionsmedicales.fr › Bactéries › Proteobacteria › Deltaproteobacteria › Bdellovibrio › Bdellovibrio bacteriovorus › Predatory bacteria as living antibiotics -...
questionsmedicales.fr › Phénomènes physiologiques › Phénomènes pharmacologiques et toxicologiques › Phénomènes pharmacologiques › Résistance aux substances › Résistance microbienne aux médicaments › Résistance bactérienne aux médicaments › Predatory bacteria as living antibiotics -...
questionsmedicales.fr › Bactéries › Bactéries à Gram positif › Predatory bacteria as living antibiotics -...
questionsmedicales.fr › Infection › Infections bactériennes et mycoses › Infections bactériennes › Infections bactériennes à Gram positif › Predatory bacteria as living antibiotics -...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Predatory bacteria as living antibiotics -...